Discover"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD
"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD
Claim Ownership

"Second Opinion" with Christina Farr, Ash Zenooz MD & Luba Greenwood JD

Author: Christina Farr, Luba Greenwood, Ash Zenooz

Subscribed: 5Played: 17
Share

Description

If you’re obsessed with health-tech and life sciences, this is the podcast for you. Second Opinion doesn't hold back. Join Luba Greenwood, Christina Farr, and Ash Zenooz as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Healthcare, health-tech and life sciences in particular, is hard to navigate even for the most seasoned professionals. Unpacking the latest technological, medical, and scientific advances, regulatory hurdles, global economic shifts, and industry and investment trends, requires a powerful combination of hosts like us.


We aim to sift through the noise and help you navigate what’s really going on in healthcare and how to spot the next win. This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space.

Christina Farr is a former investigative journalist for CNBC — during her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions. Now Christina is the author at Second Opinion, a newsletter with +20K subscribers. Joining Christina are co-hosts Luba Greenwood, JD — former CEO of Kojin Therapeutics and managing partner at Dana-Farber Cancer Institute — and Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings. 

Second Opinion is is a part of the Turpentine podcast network. Learn more: turpentine.co

7 Episodes
Reverse
In this episode of Second Opinion, Leslie Schrock, author of Bumpin' and Fertility Rules, joins Christina Farr, Ash Zenooz, and Luba Greenwood to discuss women's health, men's health, and fertility. They dive into why men need to be more involved in fertility and pregnancy conversations (it's not just a women's issue!). They address the gaps in women's health research, including the lack of understanding about how drugs and diets (like intermittent fasting) affect women differently than men. Leslie emphasizes the need for more honest, comprehensive information about pregnancy and women's health. They also discuss the potential future of women's health companies and the need for a more holistic approach to addressing health concerns beyond reproductive issues. — RECOMMENDED PODCAST: 🎙️ This Won't Last - Eavesdrop on Keith Rabois, Kevin Ryan, Logan Bartlett, and Zach Weinberg's monthly backchannel. They unpack their hottest takes on the future of tech, business, venture, investing, and politics. Apple Podcasts: https://podcasts.apple.com/us/podcast/id1765665937 Spotify: https://open.spotify.com/show/2HwSNeVLL1MXy0RjFPyOSz YouTube: https://www.youtube.com/@ThisWontLastpodcast — SPONSOR: AWELL Transform your healthcare operations with Awell! Say goodbye to manual work and Excel hell. Awell's CareOps orchestration platform helps design, implement, and improve care flows in days. Trusted by Astrana Health, Commons Clinic, and Better Health, Awell automates processes for faster care model improvements in 2 days or less. Visit awellhealth.com and mention Second Opinion for a free bootcamp. — LINKS: Subscribe to Second Opinion Newsletter: https://secondopinion.media/  Bumpin: https://www.amazon.com/Bumpin-Pregnancy-Navigating-Wonderful-Conception/dp/198213044X  Fertility Rules: https://www.amazon.com/Fertility-Rules-Definitive-Female-Reproductive-ebook/dp/B0BHTLCWZ7  — FOLLOW: Leslie: https://www.linkedin.com/in/leslieschrock/  Christina: https://www.linkedin.com/in/christinafarr/ Luba: https://www.linkedin.com/in/lubagreenwood/ Ash: https://www.linkedin.com/in/ashzenooz/ — TIMESTAMPS: (00:00) Intro (01:37) Leslie Schrock's personal journey (02:57) The reality of pregnancy (06:55) Understanding fertility and ovulation (08:47) Challenges in women's health education (13:50) Sponsor: Awell (15:00) Investing in women's health (25:54) Understanding drug metabolism in women (26:09) Men's role in women's health (26:38) The importance of inclusive pregnancy literature (28:45) Heart health: gender differences and misconceptions (30:50) Birth control and stroke risks (31:46) Challenges in women's health research (37:11) The impact of nutrition and fasting on women's health (39:19) Future of women's health companies (41:09) Suggestions on future books and research in women's health (43:55) Wrap (46:07) The debrief
In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood sit down with Owen Tripp, the CEO of Included Health. They discuss digital health models, the challenges and opportunities in selling directly to employers, growing digital health companies, and the potential return to a more personalized, concierge-style primary care model to actually make a difference in people's health. — RECOMMENDED PODCAST: 🎙️ This Won't Last - Eavesdrop on Keith Rabois, Kevin Ryan, Logan Bartlett, and Zach Weinberg's monthly backchannel. They unpack their hottest takes on the future of tech, business, venture, investing, and politics. Apple Podcasts: https://podcasts.apple.com/us/podcast/id1765665937 Spotify: https://open.spotify.com/show/2HwSNeVLL1MXy0RjFPyOSz YouTube: https://www.youtube.com/@ThisWontLastpodcast — SPONSOR: AWELL Transform your healthcare operations with Awell! Say goodbye to manual work and Excel hell. Awell's CareOps orchestration platform helps design, implement, and improve care flows in days. Trusted by Astrana Health, Commons Clinic, and Better Health, Awell automates processes for faster care model improvements in 2 days or less. Visit https://awellhealth.com and mention Second Opinion for a free bootcamp. — LINKS:  Subscribe to Second Opinion Newsletter: https://secondopinion.media/  Thinking of selling into the employer? You probably shouldn't: https://secondopinion.media/p/thinking-of-selling-into-the-employer  The thing that is breaking digital health is marketing: https://secondopinion.media/p/the-thing-that-is-breaking-digital — FOLLOW: https://www.linkedin.com/in/owenwtripp/  https://www.linkedin.com/in/christinafarr/ https://www.linkedin.com/in/lubagreenwood/ https://www.linkedin.com/in/ashzenooz/ — TIMESTAMPS: (00:00) Intro (01:16) Owen Tripp's journey in digital health (02:04) Challenges in healthcare vs. other sectors (03:29) Building a business model in healthcare (05:07) Grand Rounds: from concept to success (08:07) The role of AI in healthcare (13:48) Sponsor: Awell (14:50) Growth strategies in digital health (17:33) Selling digital health solutions to employers (19:10) Cancer care and digital health (22:22) Navigating employer sales (26:12) Utilization and awareness of digital health services (35:01) The future of digital health and primary care (38:57) The Debrief
In this episode of Second Opinion, Meg FitzGerald, a nurse turned private equity investor, offers insights into how VCs and PEs are thinking of investing in healthcare and everything founders should know to raise from both. She discusses the slowdown in private equity deals due to high interest rates and market uncertainty, and highlights the merging of venture capital and private equity in healthcare, particularly in growth capital. She shares her experience transitioning from a clinical background to private equity, underscoring the value of healthcare expertise in investment decisions. Second Opinion is a podcast from Turpentine. Learn more: www.turpentine.co — SPONSOR: AWELL 🌟 Transform your healthcare operations with Awell! Say goodbye to manual work and Excel hell. Awell's CareOps orchestration platform helps design, implement, and improve care flows in days. Trusted by Astrana Health, Commons Clinic, and Better Health, Awell automates processes for faster care model improvements in 2 days or less. Visit awellhealth.com and mention Second Opinion for a free bootcamp. — FOLLOW: Meg https://www.linkedin.com/in/meghanmfitzgerald/ Christina https://www.linkedin.com/in/christinafarr/ Luba https://www.linkedin.com/in/lubagreenwood/ Ash https://www.linkedin.com/in/ashzenooz/ — RECOMMENDED PODCAST: 🎙️ This Won't Last - Eavesdrop on Keith Rabois, Kevin Ryan, Logan Bartlett, and Zach Weinberg's monthly backchannel. They unpack their hottest takes on the future of tech, business, venture, investing, and politics. Apple Podcasts: https://podcasts.apple.com/us/podcast/id1765665937 Spotify: https://open.spotify.com/show/2HwSNeVLL1MXy0RjFPyOSz YouTube: https://www.youtube.com/@ThisWontLastpodcast — TIMESTAMPS: (00:00) Intro (00:59) Meet Meg FitzGerald: Nurse and Private Equity Investor (01:19) Private Equity in Healthcare: Current Market Dynamics (03:09) Venture Capital vs. Private Equity in Healthcare (05:00) Challenges and Opportunities in Health Tech (11:23) The Role of Private Equity (18:51) Awell (19:49) Advice for Healthcare Professionals Entering Private Equity (31:26) The debrief (35:00) Wrap
In this eye-opening episode, Christina Farr and Luba Greenwood dive deep into the challenges big tech faces in healthcare with serial entrepreneur and Cherish CEO Sumit Nagpal. Drawing from his experience founding five companies over the past 25 years and his time working with Steve Jobs at NeXT, Nagpal offers unique insights into why tech giants struggle to gain traction in the medical world. They discuss: Apple's healthcare ambitions, the untapped potential of hardware in health tech, the importance of understanding healthcare business models, and how lessons from the diagnostics industry could shape the future of digital health innovation. — SPONSOR: AWELL 🌟 Transform your healthcare operations with Awell! Say goodbye to manual work and Excel hell. Awell's CareOps orchestration platform helps design, implement, and improve care flows in days. Trusted by Astrana Health, Commons Clinic, and Better Health, Awell automates processes for faster care model improvements in 2 days or less. Visit awellhealth.com and mention Second Opinion for a free bootcamp. — LINKS:  Cherish Health: https://www.cherishhealth.com/ Subscribe to Second Opinion Newsletter: https://secondopinion.media/  — FOLLOW: Sumit: https://www.linkedin.com/in/sumitknagpal/ Christina https://www.linkedin.com/in/christinafarr/ Luba https://www.linkedin.com/in/lubagreenwood/ Ash https://www.linkedin.com/in/ashzenooz/ — RECOMMENDED PODCAST: TURPENTINE VC 🎙️ This Won't Last - Eavesdrop on Keith Rabois, Kevin Ryan, Logan Bartlett, and Zach Weinberg's monthly backchannel. They unpack their hottest takes on the future of tech, business, venture, investing, and politics. Apple Podcasts: https://podcasts.apple.com/us/podcast/id1765665937 Spotify: https://open.spotify.com/show/2HwSNeVLL1MXy0RjFPyOSz YouTube: https://www.youtube.com/@ThisWontLastpodcast — TIMESTAMPS: (00:00) Intro (02:04) Why big tech fails in healthcare (05:00) Has Apple succeeded in becoming a healthcare company? (08:44) Finding adjacencies (10:11) Billionaires' health concerns driving tech investments (14:19) Sponsor: Awell (15:19) Revolving door of healthcare leaders in tech (17:14) Culture clash in tech-healthcare partnerships (19:26) NVIDIA's successful approach to healthcare (20:21) Waystar IPO (24:10) Limited options for health tech companies (26:19) Diagnostics industry parallels with digital health (28:22) Aligning Incentives (31:54) "Follow the Money" approach to healthcare solutions (34:41) The Debrief
In this episode of Second Opinion, hosts Christina Farr, Ash Zenooz, and Luba Greenwood are joined by Daphne Zohar, Founder and CEO of Seaport Therapeutics. They talk about the complexities of drug development, the investment in biotech via big tech VCs, and the future of mental health treatments. Daphne also shares her insights on biotech today, drug development misconceptions and complex regulatory challenges the industry is facing. Daphne was the founder, CEO and a Board Member of PureTech Health (Nasdaq: PRTC, LSE: PRTC) where she also co-founded PureTech’s entities, including Karuna Therapeutics (acquired by Bristol Myers Squibb). — LINKS:  Seaport Therapeutics: https://seaporttx.com/ Seaport Therapeutics $100M series A: https://seaporttx.com/wp-content/uploads/2024/04/20240409_press_release.pdf PureTech: https://www.puretechhealth.com/  Karuna Therapeutics: https://karunatx.com/  Subscribe to Second Opinion Newsletter: https://secondopinion.media/  — FOLLOW: Daphne https://www.linkedin.com/in/daphnezohar/ Christina https://www.linkedin.com/in/christinafarr/ Luba https://www.linkedin.com/in/lubagreenwood/ Ash https://www.linkedin.com/in/ashzenooz/ — RECOMMENDED PODCAST: TURPENTINE VC 🎙️ This Won't Last - Eavesdrop on Keith Rabois, Kevin Ryan, Logan Bartlett, and Zach Weinberg's monthly backchannel. They unpack their hottest takes on the future of tech, business, venture, investing, and politics. Apple Podcasts: https://podcasts.apple.com/us/podcast/id1765665937 Spotify: https://open.spotify.com/show/2HwSNeVLL1MXy0RjFPyOSz YouTube: https://www.youtube.com/@ThisWontLastpodcast — TIMESTAMPS: (00:00) Intro (01:42) Daphne's Background and Achievements (02:29) Challenges in Mental Health and Neuro Space (05:52) Drug Development Journey and Challenges (10:40) Opportunities and Challenges for Tech Investors in Biotech (16:16) Regulatory Challenges and Industry Impact (26:39) Biosecure Act and National Security (28:02) The Debrief
On the first episode of Second Opinion, Christina Farr, Ash Zenooz, and Luba Greenwood chat with Dr. Robin Berzin, the Founder & CEO of Parsley Health. Robin shares her journey from being a physician to founding Parsley Health, a digital health company that uses root cause medicine to drive powerful outcomes for patients with complex health needs. She also talks about how breakthroughs in data and AI are helping redefine primary care with data-driven insights. They explore crucial healthcare questions like "Whose job is it to prevent chronic disease?" and discuss whether digital health can deliver on prevention, treatment, and longevity. They reflect on the shortcomings of primary care, the impact of the standard American diet on health, the latest studies on cortisol, and the importance of a holistic approach to medicine. Thank you to our sponsor Awell, the leading CareOps platform. — SPONSOR: AWELL 🌟 Transform your healthcare operations with Awell! Say goodbye to manual work and Excel hell. Awell's CareOps orchestration platform helps design, implement, and improve care flows in days. Trusted by Astrana Health, Commons Clinic, and Better Health, Awell automates processes for faster care model improvements in 2 days or less. Visit awellhealth.com and mention Second Opinion for a free bootcamp. — LINKS: Subscribe to Robin’s Newsletter: https://robinberzinmd.com/  Subscribe to Parsley Health Newsletter: https://www.parsleyhealth.com/blog/category/news/  Parsley Health: https://www.parsleyhealth.com   ARTICLES MENTIONED: Health care's "churn" problem: https://secondopinion.media/p/health-cares-churn-problem  How to balance cortisol levels to increase energy and lose weight: https://robinberzinmd.com/how-to-balance-cortisol-levels-to-increase-energy-and-lose-weight/  A Lot of What You’ve Heard About Cortisol Is Wrong: https://www.wsj.com/health/wellness/cortisol-stress-hormone-adrenal-fatigue-02aab49a  — FOLLOW: https://www.linkedin.com/in/robin-berzin-md/ https://www.linkedin.com/in/christinafarr/ https://www.linkedin.com/in/lubagreenwood/ https://www.linkedin.com/in/ashzenooz/ Subscribe to Second Opinion Newsletter: https://secondopinion.media/  — TIMESTAMPS: (00:00) Intro (02:30) Robin Berzin's Journey: From Physician to CEO of Parsley Health (07:11) Functional Medicine (aka Root Cause Medicine) and Parsley Health (09:31) Challenges in Traditional Healthcare (11:06) The Role of AI and Data in Healthcare (14:34) Whose Job Is It To Prevent Chronic Disease? (21:19) SPONSOR: Awell Health (22:22) Healthcare’s “Churn” Problem, Insurance and Healthcare Costs (27:57) Partnering with Insurance Companies (30:43) How Diet and Lifestyle Impact Health (34:34) The Role of Cortisol in the Body (36:32) Wrap This podcast is part of the Turpentine podcast network. Learn more: turpentine.co
Second Opinion doesn't hold back. Join Christina Farr, Ash Zenooz, Luba Greenwood, as they bring influential entrepreneurs, experts and investors into the ring for candid conversations at the frontlines of healthcare and digital health every week. Episode 1 with Robin Berzin, CEO of Parsley Health, will be available starting on July 31, 2024. Subscribe to Second Opinion wherever you get your podcasts. Learn more at https://www.podpage.com/secondopinion/ Til then, meet your hosts:  Christina Farr draws on a decade of experience covering the industry as a reporter at CNBC, Fast Company and Reuters, as well as an investor at OMERS Ventures. During her tenure as a reporter, she broke some big health-tech stories ranging from Amazon’s first moves into the sector to Apple’s secretive acquisitions.  Luba Greenwood, JD is a veteran biotech CEO and investor. She is the managing partner and founder of the Dana-Farber Cancer Institute venture fund and has served as CEO and Chair of multiple companies including Kojin. She has led over $10b in deals and served in leadership roles at large healthcare and tech companies, including Roche and Google. She is a thought leader in the industry and senior lecturer at Harvard. Ash Zenooz, MD — former CEO of Commure and partner at Luxeda Holdings. As former CEO of Commure, she drove over 550% ARR growth and led a merger. Previously, she grew Salesforce's global health and life sciences unit to $2.5b ARR. Ash also served as Chief Medical Officer at the VA, overseeing an $80B portfolio and leading telehealth and precision medicine reforms.  This season, we’re tackling meaty topics like biosecurity, the latest in telemedicine, why patient acquisition is so hard, and the pros and cons of VC versus private equity in funding startups in the healthtech space.